{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:35:06Z","timestamp":1791837306904,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7698","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/nature26138","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T17:27:45Z","timestamp":1521566865000},"page":"673-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":270,"title":["Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance"],"prefix":"10.1038","volume":"555","author":[{"given":"Devram S.","family":"Ghorpade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Nicoloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Czech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Tabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"BFnature26138_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/BJ20100330","volume":"429","author":"S Dasgupta","year":"2010","unstructured":"Dasgupta, S. et al. NF-\u03baB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem. J. 429, 451\u2013462 (2010)","journal-title":"Biochem. J."},{"key":"BFnature26138_CR2","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796\u20131808 (2003)","journal-title":"J. Clin. Invest."},{"key":"BFnature26138_CR3","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821\u20131830 (2003)","journal-title":"J. Clin. Invest."},{"key":"BFnature26138_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.soard.2010.05.013","volume":"7","author":"OT Hardy","year":"2011","unstructured":"Hardy, O. T. et al. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity. Surg. Obes. Relat. Dis. 7, 60\u201367 (2011)","journal-title":"Surg. Obes. Relat. Dis."},{"key":"BFnature26138_CR5","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1042\/CS20160005","volume":"130","author":"M Bl\u00fcher","year":"2016","unstructured":"Bl\u00fcher, M. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? Clin. Sci. (Lond.) 130, 1603\u20131614 (2016)","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnature26138_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance. Science 259, 87\u201391 (1993)","journal-title":"Science"},{"key":"BFnature26138_CR7","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","volume":"121","author":"CN Lumeng","year":"2011","unstructured":"Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111\u20132117 (2011)","journal-title":"J. Clin. Invest."},{"key":"BFnature26138_CR8","doi-asserted-by":"publisher","first-page":"8278","DOI":"10.1073\/pnas.1300492110","volume":"110","author":"M Aouadi","year":"2013","unstructured":"Aouadi, M. et al. Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice. Proc. Natl Acad. Sci. USA 110, 8278\u20138283 (2013)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature26138_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2012.03.002","volume":"15","author":"L Ozcan","year":"2012","unstructured":"Ozcan, L. et al. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab. 15, 739\u2013751 (2012)","journal-title":"Cell Metab."},{"key":"BFnature26138_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cmet.2013.10.011","volume":"18","author":"L Ozcan","year":"2013","unstructured":"Ozcan, L. et al. Activation of calcium\/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab. 18, 803\u2013815 (2013)","journal-title":"Cell Metab."},{"key":"BFnature26138_CR11","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.celrep.2016.05.006","volume":"15","author":"L Ozcan","year":"2016","unstructured":"Ozcan, L. et al. Hepatocyte DACH1 is increased in obesity via nuclear exclusion of HDAC4 and promotes hepatic insulin resistance. Cell Reports 15, 2214\u20132225 (2016)","journal-title":"Cell Reports"},{"key":"BFnature26138_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1078\/0171-9335-00302","volume":"82","author":"E Boonacker","year":"2003","unstructured":"Boonacker, E. & Van Noorden, C. J. The multifunctional or moonlighting protein CD26\/DPPIV. Eur. J. Cell Biol. 82, 53\u201373 (2003)","journal-title":"Eur. J. Cell Biol."},{"key":"BFnature26138_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1507\/endocrj.EJ12-0158","volume":"59","author":"Y Kirino","year":"2012","unstructured":"Kirino, Y., Sei, M., Kawazoe, K., Minakuchi, K. & Sato, Y. Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people. Endocr. J. 59, 949\u2013953 (2012)","journal-title":"Endocr. J."},{"key":"BFnature26138_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2337\/db10-1707","volume":"60","author":"D Lamers","year":"2011","unstructured":"Lamers, D. et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60, 1917\u20131925 (2011)","journal-title":"Diabetes"},{"key":"BFnature26138_CR15","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker, D. J. & Nauck, M. A. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368, 1696\u20131705 (2006)","journal-title":"Lancet"},{"key":"BFnature26138_CR16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"A Guilherme","year":"2008","unstructured":"Guilherme, A., Virbasius, J. V., Puri, V. & Czech, M. P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 367\u2013377 (2008)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnature26138_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1463-1326.2005.00539.x","volume":"7","author":"S Ristic","year":"2005","unstructured":"Ristic, S., Byiers, S., Foley, J. & Holmes, D. Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response. Diabetes Obes. Metab. 7, 692\u2013698 (2005)","journal-title":"Diabetes Obes. Metab."},{"key":"BFnature26138_CR18","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.2337\/dc06-0703","volume":"29","author":"P Aschner","year":"2006","unstructured":"Aschner, P. et al. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 29, 2632\u20132637 (2006)","journal-title":"Diabetes Care"},{"key":"BFnature26138_CR19","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1007\/s00125-006-0416-z","volume":"49","author":"I Raz","year":"2006","unstructured":"Raz, I. et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia 49, 2564\u20132571 (2006)","journal-title":"Diabetologia"},{"key":"BFnature26138_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12020-012-9596-0","volume":"41","author":"E Kutoh","year":"2012","unstructured":"Kutoh, E. & Ukai, Y. Alogliptin as an initial therapy in patients with newly diagnosed, drug na\u00efve type 2 diabetes: a randomized, control trial. Endocrine 41, 435\u2013441 (2012)","journal-title":"Endocrine"},{"key":"BFnature26138_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/dom.12092","volume":"15","author":"T Kadowaki","year":"2013","unstructured":"Kadowaki, T. & Kondo, K. Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus. Diabetes Obes. Metab. 15, 810\u2013818 (2013)","journal-title":"Diabetes Obes. Metab."},{"key":"BFnature26138_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/dmrr.2613","volume":"31","author":"CH Jung","year":"2015","unstructured":"Jung, C. H. et al. A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Diabetes Metab. Res. Rev. 31, 295\u2013306 (2015)","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnature26138_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cmet.2016.10.007","volume":"25","author":"EE Mulvihill","year":"2017","unstructured":"Mulvihill, E. E. et al. Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis. Cell Metab. 25, 152\u2013165 (2017)","journal-title":"Cell Metab."},{"key":"BFnature26138_CR24","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.4049\/jimmunol.161.8.4318","volume":"161","author":"NH Senden","year":"1998","unstructured":"Senden, N. H. et al. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J. Immunol. 161, 4318\u20134324 (1998)","journal-title":"J. Immunol."},{"key":"BFnature26138_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.ATV.0000151279.35780.2d","volume":"25","author":"G Busch","year":"2005","unstructured":"Busch, G. et al. Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25, 461\u2013466 (2005)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnature26138_CR26","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1182\/blood.V74.5.1583.1583","volume":"74","author":"MP McGee","year":"1989","unstructured":"McGee, M. P., Wallin, R., Wheeler, F. B. & Rothberger, H. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study. Blood 74, 1583\u20131590 (1989)","journal-title":"Blood"},{"key":"BFnature26138_CR27","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1128\/MCB.25.17.7743-7757.2005","volume":"25","author":"K Ohnuma","year":"2005","unstructured":"Ohnuma, K. et al. CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Mol. Cell. Biol. 25, 7743\u20137757 (2005)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature26138_CR28","first-page":"2326","volume":"7","author":"P Zuo","year":"2015","unstructured":"Zuo, P. et al. Factor Xa induces pro-inflammatory cytokine expression in RAW 264.7 macrophages via protease-activated receptor-2 activation. Am. J. Transl. Res. 7, 2326\u20132334 (2015)","journal-title":"Am. J. Transl. Res."},{"key":"BFnature26138_CR29","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00463.2010","volume":"300","author":"AD Dobrian","year":"2011","unstructured":"Dobrian, A. D. et al. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. Am. J. Physiol. Endocrinol. Metab. 300, E410\u2013E421 (2011)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnature26138_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molmet.2015.04.003","volume":"4","author":"DJ Pedersen","year":"2015","unstructured":"Pedersen, D. J. et al. A major role of insulin in promoting obesity-associated adipose tissue inflammation. Mol. Metab. 4, 507\u2013518 (2015)","journal-title":"Mol. Metab."},{"key":"BFnature26138_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1609243","volume":"376","author":"K Fitzgerald","year":"2017","unstructured":"Fitzgerald, K. et al. A highly durable RNAi therapeutic inhibitor of PCSK9. N. Engl. J. Med. 376, 41\u201351 (2017)","journal-title":"N. Engl. J. Med."},{"key":"BFnature26138_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature12875","volume":"506","author":"L Lisowski","year":"2014","unstructured":"Lisowski, L. et al. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 506, 382\u2013386 (2014)","journal-title":"Nature"},{"key":"BFnature26138_CR33","doi-asserted-by":"publisher","first-page":"27290","DOI":"10.1074\/jbc.M112.374777","volume":"287","author":"SM Ebert","year":"2012","unstructured":"Ebert, S. M. et al. Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy. J. Biol. Chem. 287, 27290\u201327301 (2012)","journal-title":"J. Biol. Chem."},{"key":"BFnature26138_CR34","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1172\/JCI77995","volume":"125","author":"X Mu","year":"2015","unstructured":"Mu, X. et al. Hepatocellular carcinoma originates from hepatocytes and not from the progenitor\/biliary compartment. J. Clin. Invest. 125, 3891\u20133903 (2015)","journal-title":"J. Clin. Invest."},{"key":"BFnature26138_CR35","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1172\/JCI118951","volume":"98","author":"H Shimano","year":"1996","unstructured":"Shimano, H. et al. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 98, 1575\u20131584 (1996)","journal-title":"J. Clin. Invest."},{"key":"BFnature26138_CR36","first-page":"e50707","volume":"22","author":"JS Orr","year":"2013","unstructured":"Orr, J. S., Kennedy, A. J. & Hasty, A. H. Isolation of adipose tissue immune cells. J. Vis. Exp. 22, e50707 (2013)","journal-title":"J. Vis. Exp."},{"key":"BFnature26138_CR37","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1074\/mcp.M114.038836","volume":"13","author":"A Nazarian","year":"2014","unstructured":"Nazarian, A. et al. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. Mol. Cell. Proteomics 13, 3082\u20133096 (2014)","journal-title":"Mol. Cell. Proteomics"},{"key":"BFnature26138_CR38","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/nature07774","volume":"458","author":"M Aouadi","year":"2009","unstructured":"Aouadi, M. et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458, 1180\u20131184 (2009)","journal-title":"Nature"},{"key":"BFnature26138_CR39","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1021\/acs.molpharmaceut.5b00831","volume":"13","author":"JL Cohen","year":"2016","unstructured":"Cohen, J. L. et al. Peptide- and amine-modified glucan particles for the delivery of therapeutic siRNA. Mol. Pharm. 13, 964\u2013978 (2016)","journal-title":"Mol. Pharm."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature26138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature26138","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature26138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature26138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T18:10:53Z","timestamp":1693591853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature26138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":39,"journal-issue":{"issue":"7698","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["BFnature26138"],"URL":"https:\/\/doi.org\/10.1038\/nature26138","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"27 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}